FFG
TEVA icon

Fortem Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Fortem Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17,500
Closed -$170K – 180
2021
Q3 		$170K Buy
17,500
+2,000
+13% +$18.7K 0.09% 168
2021
Q2 		$153K Sell
15,500
-10,000
-39% -$106K 0.08% 162
2021
Q1 		$294K Sell
25,500
-2,500
-9% -$28.7K 0.17% 138
2020
Q4 		$270K Sell
28,000
-1,000
-3% -$9.58K 0.16% 127
2020
Q3 		$261K Buy
29,000
+2,500
+9% +$26.4K 0.19% 122
2020
Q2 		$327K Hold
26,500
– – 0.25% 93
2020
Q1 		$238K Buy
26,500
+4,000
+18% +$41K 0.22% 91
2019
Q4 		$221K Buy
22,500
+500
+2% +$4.46K 0.16% 105
2019
Q3 		$151K Sell
22,000
-22,200
-50% -$170K 0.13% 105
2019
Q2 		$408K Buy
+44,200
New +$533K 0.41% 60
2019
Q1 		– Sell
-15,900
Closed -$245K – 146
2018
Q4 		$245K Buy
+15,900
New +$326K 0.3% 75

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Fortem Financial Group's TEVA Position: Q4 2021 in Review

Fortem Financial Group sold out of Teva Pharmaceuticals (TEVA) in Q4 2021, closing a stake of 17,500 shares — an estimated $170K sold.

Fortem Financial Group first reported a position in TEVA in Q4 2018 and held it in 11 quarters. The position peaked at $408K in Q2 2019. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

  • Fortem Financial Group reported no remaining Teva Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Fortem Financial Group sold 17,500 Teva Pharmaceuticals shares in Q4 2021, an estimated $170K.
  • Fortem Financial Group first reported a position in Teva Pharmaceuticals in Q4 2018 and held it in 11 quarters.
  • Fortem Financial Group's Teva Pharmaceuticals position peaked at $408K in Q2 2019.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2021.

Based on Fortem Financial Group's 13F filing for Q4 2021, filed 20 Jan 2022.